It has also been reported that AD patients have higher PCSK9 expression and protein levels in the frontal cortex and CSF compared with non-AD subjects, more remarkably in ApoE4 carriers than in non-carriers, reaching statistical significance in the AD group. Here, PCSK9 is linked to Alzheimer disease.